Cannabis and Premenstrual Syndrome (PMS)
What the evidence actually says about using cannabis for cramps, mood swings, and other PMS symptoms.
PMS is one of the most common reasons people self-medicate with cannabis, and one of the least studied. Survey data shows lots of women report relief, but we have almost no controlled trials. The honest answer is that cannabis probably helps some people with cramps, sleep, and mood the same way it helps with general pain and anxiety — not because there's a special PMS mechanism. Topicals marketed for menstrual pain are mostly unproven. Don't believe the 'cannabis cures PMS' marketing; do take the user-reported relief seriously as a signal worth more research.
Plain-language summary
PMS is a cluster of physical and emotional symptoms — cramps, bloating, breast tenderness, irritability, low mood, sleep disturbance, food cravings — that show up in the week or two before menstruation and resolve when bleeding starts. Premenstrual dysphoric disorder (PMDD) is a more severe form recognized in the DSM-5 [1].
Many people use cannabis for these symptoms. A 2022 survey of over 1,000 menstruating cannabis users in California found that roughly 9 in 10 reported using it to manage menstrual or premenstrual symptoms, most commonly for cramps, mood, and sleep [2]. But survey reports are not the same as evidence that it works — they tell us what people do, not whether it's better than placebo, ibuprofen, or an SSRI.
This article is not medical advice. PMS and PMDD can mimic or coexist with thyroid disease, depression, endometriosis, and other conditions. Talk to a clinician before substituting cannabis for an evaluation or treatment plan.
What probably works
Honestly? Nothing in cannabis has reached the "probably works" bar specifically for PMS. There are no published randomized controlled trials of cannabis or cannabinoids for PMS or PMDD as of this writing No data.
What we can say with more confidence is borrowed from adjacent literatures:
- Cannabis can reduce acute pain perception in some chronic pain conditions Weak / limited [3]. If your dominant PMS symptom is cramping, that general pain-relief effect may apply, though menstrual cramps (prostaglandin-driven) are mechanistically different from neuropathic or musculoskeletal pain.
- THC at low doses can reduce situational anxiety and improve subjective sleep onset Weak / limited [4]. Both are relevant to PMS irritability and insomnia.
So the most defensible statement is: cannabis may help PMS symptoms through the same general mechanisms it helps pain, anxiety, and sleep — not through any PMS-specific pathway.
What might work
- Inhaled THC or balanced THC:CBD for cramps and mood. Survey users overwhelmingly prefer flower and report symptom improvement Weak / limited [2]. Onset is fast, which matches the episodic nature of cramp flares.
- Oral CBD for irritability and sleep. CBD has some controlled-trial support for anxiety Weak / limited [5], and PMS-related irritability might respond similarly. No PMS-specific trials exist.
- Low-dose edibles for overnight symptom control. Extrapolated from chronic pain and sleep literature Weak / limited.
Note the pattern: every "might work" claim here is extrapolated from other conditions. That's a legitimate clinical move, but it's not the same as direct evidence.
What doesn't work or has weak evidence
- Cannabis vaginal suppositories for cramps. Heavily marketed, sometimes at premium prices. There are zero published controlled trials showing they outperform placebo, oral cannabis, or a heating pad No data. The pelvic absorption story is biologically plausible but unproven.
- CBD topicals for cramps. Skin-applied CBD does not meaningfully reach deep pelvic organs Weak / limited. Any relief is more likely from massage, warmth, or placebo than from the cannabinoid.
- "Indica for PMS" guidance. The indica/sativa distinction does not reliably predict chemistry or effects Disputed [6]. Pick by cannabinoid and terpene content, not category.
- Cannabis as a disease-modifying treatment for PMDD. No evidence it changes the underlying hormonal sensitivity that drives PMDD No data. SSRIs do have that evidence [1].
- High-THC products being "stronger medicine." Higher THC increases anxiety and panic risk, especially in inexperienced users Strong evidence [7]. For premenstrual irritability, more THC can backfire.
What we don't know
The list of unknowns is longer than the list of knowns:
- Whether cannabis outperforms ibuprofen or naproxen for menstrual cramps.
- Whether any cannabinoid ratio is better than another for PMS.
- Whether cannabis interacts with hormonal contraceptives in a clinically meaningful way (some signal that CBD inhibits CYP enzymes that metabolize hormones Weak / limited [8]).
- Whether long-term cannabis use changes menstrual cycle length, ovulation, or fertility. Some observational data suggest possible effects on cycle regularity and ovulation Weak / limited [9].
- Whether PMDD specifically responds to cannabinoids.
- Optimal dose, timing (luteal-phase-only vs. continuous), and route.
This is a field crying out for properly designed trials. It hasn't gotten them, largely because of cannabis's federal scheduling in the US and historic underfunding of menstrual health research.
Comparison with standard treatments
First-line, evidence-based treatments for PMS and PMDD include [1][10]:
- NSAIDs (ibuprofen, naproxen) — strong evidence for menstrual cramps. Mechanism (prostaglandin inhibition) directly targets the cause. Strong evidence
- Combined hormonal contraceptives — strong evidence for physical PMS symptoms; mixed for mood. Strong evidence
- SSRIs (continuous or luteal-phase) — strong evidence for PMDD and severe PMS mood symptoms. Strong evidence
- Cognitive behavioral therapy — moderate evidence for PMS mood symptoms. Strong evidence
- Calcium, vitamin B6, exercise — modest but real evidence for some symptoms. Weak / limited
Cannabis has not been compared head-to-head with any of these. For someone with mild-to-moderate PMS who already uses cannabis recreationally, adding symptom-timed use is reasonable. For someone with PMDD or significantly impairing PMS, the evidence-based ladder (SSRI, hormonal contraception, CBT) is where to start — cannabis is at best an adjunct.
Risks and considerations
- Anxiety and panic at higher THC doses, particularly when PMS irritability is already elevated Strong evidence [7].
- Tolerance and dependence with daily use. Cannabis use disorder affects roughly 1 in 10 regular users and higher rates in those who start young Strong evidence [11].
- Drug interactions. CBD inhibits CYP3A4 and CYP2C19, which metabolize many drugs including some SSRIs and hormonal contraceptive components Weak / limited [8]. If you're on prescription medication, ask your pharmacist.
- Pregnancy. If there's any chance of pregnancy, cannabis is not recommended — prenatal exposure is associated with lower birth weight and developmental effects Strong evidence [12].
- Product quality. Especially for products marketed at women (suppositories, "period" tinctures), the regulated-cannabis market has wide variability in dose accuracy.
- Symptom masking. Severe cyclical pelvic pain can be endometriosis or adenomyosis. Self-treating with cannabis without a workup can delay diagnosis by years.
Bottom line: this is not medical advice. Cannabis is a plausible, popular, and under-studied option for PMS symptom relief. Treat the user-reported benefit as real but unverified, treat the marketed products as mostly unproven, and treat the underlying condition with a clinician who can rule out other causes.
Sources
- Book American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). APA Publishing.
- Peer-reviewed Slavin, M. N., Farmer, S., & Earleywine, M. (2022). Cannabis use to manage premenstrual symptoms among women in California. Journal of Cannabis Research, 4(1).
- Peer-reviewed Whiting, P. F., et al. (2015). Cannabinoids for medical use: a systematic review and meta-analysis. JAMA, 313(24), 2456-2473.
- Peer-reviewed Stith, S. S., et al. (2019). The association between cannabis product characteristics and symptom relief. Scientific Reports, 9, 2712.
- Peer-reviewed Bergamaschi, M. M., et al. (2011). Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology, 36(6), 1219-1226.
- Peer-reviewed Watts, S. W., et al. (2021). Cannabis labelling is associated with genetic variation in terpene synthase genes. Nature Plants, 7, 1330-1334.
- Peer-reviewed Crippa, J. A., et al. (2009). Effects of cannabidiol (CBD) on regional cerebral blood flow and acute anxiety induced by THC. Journal of Psychopharmacology, 23(8), 880-887.
- Peer-reviewed Brown, J. D., & Winterstein, A. G. (2019). Potential adverse drug events and drug-drug interactions with medical and consumer cannabidiol (CBD) use. Journal of Clinical Medicine, 8(7), 989.
- Peer-reviewed Jukic, A. M. Z., et al. (2007). Lifestyle and reproductive factors associated with follicular phase length. Journal of Women's Health, 16(9), 1340-1347.
- Government American College of Obstetricians and Gynecologists. (2023). Premenstrual Syndrome (PMS) — Frequently Asked Questions. ↗
- Government National Academies of Sciences, Engineering, and Medicine. (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. National Academies Press.
- Government U.S. Surgeon General. (2019). Marijuana Use and the Developing Brain — Advisory on Marijuana Use and the Developing Brain. ↗
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Cannabis and Chronic Pain — What the evidence actually says about cannabis for long-term pain, separated from the mark...